recoveryELISA TNFα Neutralization Rate/Adalimumab Kit (RTA), IvD, CE certified

recoveryELISA TNFα Neutralization Rate/Adalimumab Kit (RTA), IvD, CE certified | R222 | BioTeZ

Product Features:

Type: ELISA

Reactivity : Adalimumab and free TNF alpha

Antigen : Adalimumab and free TNF alpha

Detection Range : 0.7 – 30 µg/mL Adalimumab; TNF alpha in sample without Adalimumab: 4-400ng/ml;TNF alpha in sample with Adalimumab: 4-160ng/ml

Application : The unique recoveryELISA technology monitors parallel the free drug Adalimumab, the free antigen TNF alpha concentration and the neutralization rate of TNF alpha in patient sera during Adalimumab therapy.

Description : The unique recoveryELISA technology monitors parallel the free drug Adalimumab, the free antigen TNF alpha concentration and the neutralization rate of TNF alpha in patient sera during Adalimumab therapy. This next generation therapeutic drug monitoring tool can be used by diagnostic laboratories and medical doctors for research to find a personalized medication dose for each patient individually.

Research Area : Therapies and studies with Adalimumab, Rheumatic Diseases

Specificity : Adalimumab and free TNF alpha

Immunogen : N/A

Sensitivity : Adalimumab: 0.7 µg/mL; TNF alpha: 4ng/ml

Predicted Reactivity : Adalimumab and free TNF alpha

Cross Reactivity : N/A

Minimum Shelf life time in months : 6 months

Storage Shipping Temp Min : ice pack to temperature >25°C

Storage Shipping Temp Max : 37°C

Storage Long Term : 2-8°C

Principle : Sandwich-ELISA

Components : microplate, buffers, antibody conjugate, standards, TMB reagent, stopping solution

Characteristics : Kit

Sample Type :

Format : 96 well microplate